LPL Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$885K Buy
31,500
+1,000
+3% +$26.6K ﹤0.01% 4287
2025
Q4
$759K Buy
30,500
+19,000
+165% +$479K ﹤0.01% 4348
2025
Q3
$293K Sell
11,500
-60,000
-84% -$1.48M ﹤0.01% 5065
2025
Q2
$1.73M Buy
71,500
+27,000
+61% +$630K ﹤0.01% 3262
2025
Q1
$1.13M Buy
44,500
+20,100
+82% +$526K ﹤0.01% 3450
2024
Q4
$647K Sell
24,400
-20,600
-46% -$559K ﹤0.01% 3868
2024
Q3
$1.3M Sell
45,000
-2,200
-5% -$64.2K ﹤0.01% 3139
2024
Q2
$1.32M Buy
47,200
+46,830
+12,657% +$1.29M ﹤0.01% 2986
2024
Q1
$1.03M Buy
+370
New +$10.3K ﹤0.01% 3158

Other funds holding PFE

LPL Financial's PFE Position: Q1 2026 in Review

LPL Financial increased its Pfizer (PFE) stake by 0.94% in Q1 2026, buying an estimated $3.31M and bringing the position to 13,393,661 shares worth $376M. The position accounts for 0.1% of the portfolio, ranked #206.

LPL Financial first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • LPL Financial held 13,393,661 shares of Pfizer worth $376M as of Q1 2026.
  • LPL Financial bought 124,181 Pfizer shares in Q1 2026, an estimated $3.31M.
  • Pfizer made up 0.1% of LPL Financial's portfolio in Q1 2026, its #206 holding.
  • LPL Financial first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.